Adipocyte Hypoxia-Inducible Factor 2α Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism
Adipocyte Hypoxia-Inducible Factor 2α Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism
复制标题
脂肪细胞缺氧诱导因子 2 α 通过促进脂肪神经酰胺分解代谢来抑制动脉粥样硬化
DOI:
10.1016/j.cmet.2019.09.016
复制
发表时间:
2019-11-05
期刊:
影响因子:
29
通讯作者:
Jiang, Changtao
中科院分区:
文献类型:
--
作者:
Zhang, Xingzhong;Zhang, Yangming;Jiang, Changtao
Obesity-induced adipose dysfunction is a major contributor to atherosclerosis. Cold exposure has been reported to affect atherosclerosis through regulation of adipose function, but the mechanism has not been well clarified. Here, adipocyte hypoxia-inducible factor 2 alpha (HIF-2 alpha) was upregulated after mild cold exposure at 16 degrees C and mediated cold-induced thermogenesis. Adipocyte HIF-2 alpha deficiency exacerbated Western-diet-induced atherosclerosis by increasing adipose ceramide levels, which blunted hepatocyte cholesterol elimination and thermogenesis. Mechanistically, Acer2, the gene encoding alkaline ceramidase 2, was identified as a novel target gene of HIF-2 alpha, triggering ceramide catabolism. Adipose overexpression of ACER2 rescued adipocyte HIF-2 alpha-deficiency-induced exacerbation of atherosclerosis. Furthermore, activation of adipose HIF-2 alpha by the HIF prolyl hydroxylase inhibitor FG-4592 had protective effects on atherosclerosis, accompanied by a reduction in adipose and plasma ceramide and plasma cholesterol levels. This study highlights adipocyte HIF-2 alpha as a putative drug target against atherosclerosis.